Making the diagnosis of fungal infection: When to start treatment

International Journal of Antimicrobial Agents

Volumn 16, Issue 3, 2000, Pages 323-329

  Martino, Pietro ^a   Girmenia, Corrado ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Detection fungal antigens; Fungal antibodies; Fungal infection in cancer patients; Neutropenia and fungi

Indexed keywords

ANTIFUNGAL AGENT; FUNGUS ANTIGEN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA; CLINICAL FEATURE; EARLY DIAGNOSIS; FEVER; FUNGEMIA; FUNGUS CULTURE; FUSARIUM; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SERODIAGNOSIS; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; TRICHOSPORON BEIGELII;

ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; DNA, FUNGAL; HUMANS; IMMUNOLOGIC TESTS; MYCOSES; NEOPLASMS; NEUTROPENIA; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0033727867     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00257-0     Document Type: Article

References (64)

1. Fungal infections complicating acute leukemia
2. Fever in the pediatric and young adult patients with cancer. A prospective study of 1001 episodes
3. Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review
4. Candida and Aspergillus infections in immunocompromised patients: An overview
5. Epidemiology and control of fungal infections
6. Diagnosis and treatment of invasive fungal infections in cancer patients
7. Are we making progress in antifungal therapy?
8. The potential role of cytokine therapy for fungal infections in patients with cancer: Is recovery from neutropenia all that needed?
9. Spontaneous pneumothorax in leukemia patients: First sign of pulmonary mycetoma
10. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
11. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis
12. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
13. Hepatic candidiasis in cancer patients. The evolving picture of the syndrome
14. Hepatosplenic fungal disease: Diagnostic accuracy and spectrum of appearances on MR imaging
15. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: A retrospective study
16. Significance of isolation of Aspergillus from respiratory tract in diagnosis of invasive pulmonary aspergillosis
17. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
18. Candida colonization and systemic infection in neutropenic patients: A retrospective study
19. A prospective study on Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients
20. The epidemiology of hematogenous candidiasis caused by different Candida species
21. Fungemia in leukemia patients
22. Detection of Candida in blood smears of patients with hematologic malignancies
23. Blastoschizomyces capitatus: An emerging cause of invasive fungal disease in leukemia patients
24. The emerging role of fusarium infections in patients with cancer
25. Invasive fusarium solani infections in patients with acute leukemia
26. Clinical patterns of Fusarium infections in immunocompromised patients
27. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: 10 years' experience at a cancer center and implications for management
28. Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC plus 26 anaerobic blood culture bottle, and 10-ml isolator blood culture system for detection of fungemia and bacteremia
29. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection
30. The treatment of candidemia
31. Should all patients with candidemia be treated with antifungal agents?
32. Candidemia in a tertiary care hospital: Epidemiology, risk factors and predictors of mortality
33. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy
34. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patients: Frequency, characteristics, and evaluation of factors influencing outcome
35. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes
36. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
37. Catheters and candidemia
38. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains
39. Breakthrough candidemia during antifungal treatment with fluconazole of patients with hematologic malignancies
40. The treatment of candidemia
41. Immunodiagnosis of invasive fungal infection
42. Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor
43. Diagnosis of systemic candidiasis by an enzyme-linked dot-immunobinding assay for a circulating immunodominant 47-kDa antigen
44. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis
45. Value of the Cand-tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients
46. Detection of serum Candida antigens by enzime-linked immunosorbent assay and a latex agglutination test with anti-Candida albicans and anti-Candida krusei antibodies
47. Fungemia in the immunocompromised host. Changing pattern, antigenemia, high mortality
48. Enolase antigen, mannan antigen, Cand-tec antigen, and β-glucan in patients with candidemia
49. Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients
50. Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection
51. Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease
52. Serological techniques for diagnosis of fungal infection
53. Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis
54. Use of a monoclonal antibody in a dot-immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis
55. Serodiagnosis of candidiasis, aspergillosis and cryptococcosis
56. Candida mannoproteinemia detection as an aid for successful fluconazole treatment of neutropenic enterocolitis
57. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients
58. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples
59. Detection of antigen in sera of patients with invasive aspergillosis: Intra- and inter-laboratory reproducibility. The Duch interuniversitary working party for invasive mycoses
60. PCR and single-strand conformational polymorphism for recognition of medically opportunistic fungi
61. The detection of Aspergillus spp. by the PCR and its evaluation in bronchoalveolar lavage fluid
62. Comparison of GM-antigen detection and competitive polymerase chain reaction for diagnosing IA
63. Detection and identification of fungal pathogens in blood by using molecular probes
64. PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies